Filing Details
- Accession Number:
- 0001019695-12-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-14 11:02:19
- Reporting Period:
- 2012-06-12
- Filing Date:
- 2012-06-14
- Accepted Time:
- 2012-06-14 11:02:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1019695 | Arqule Inc | ARQL | Pharmaceutical Preparations (2834) | 043221586 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1139036 | J Patrick Zenner | C/O Arqule, Inc. 19 Presidential Way Woburn MA 01801 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-06-12 | 4,000 | $6.47 | 35,300 | No | 4 | P | Indirect | By Zenner Margaret Trust BK |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Zenner Margaret Trust BK |
Footnotes
- Reflects the weighted average price as the shares were purchased in multiple transactions. The per share transaction price ranged from $6.43 to $6.48. The Reporting Person hereby undertakes to provide, upon request, by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.